skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Gain insights into the oncology deals making headlines with exclusive reporting and analysis from Scrip. Explore a snapshot view of the year’s biggest oncology deals so far, in a convenient infographic and go deeper into two major cancer deals that occurred in September with your free article pack.

Scrip Oncology Deals Article Coverage

Explore two recent cancer deals making waves in pharma:

  • “Gilead Buys Pipeline-In-A-Product With $21bn Immunomedics Deal"
  • “Twice As Nice: Seattle Genetics, Merck & Co. Partner On Two Cancer Drugs”
Oncology Deals Article Coverage

Cancer Deals That Grabbed Headlines In 2020

Your snapshot view of the cancer deals that grabbed headlines in 2020.

Keep pace with the oncology deals that shaped the market in 2020 with your free Scrip infographic. You’ll discover a data-packed overview of:

  • The top 23 cancer deals with an upfront value greater than or equal to $100m
  • The highest value oncology deals of the year so far
  • Top cancer alliances of 2020
  • Deals by company
  • And more
2020’s Biggest Deals at a Glance

Read also

;

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: